loader2
Partner With Us NRI

Kabra Drugs Ltd share Price Today

Company details

7.91
7.91
3.18
7.91
6M Return 40.00%
1Y Return 46.48%
Mkt Cap.(Cr) 3.47
Volume 250
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 250

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Kabra Drugs Ltd shares SWOT Analysis

Strengths (4)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Rising Net Cash Flow and Cash from Operating activity
  • New 52 week high today

Weakness (3)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Low Piotroski Score : Companies with weak financials
  • Annual net profit declining for last 2 years

Opportunity (2)

  • Highest Recovery from 52 Week Low
  • Stock with Low PE (PE < = 10)

Threats (0)

Data not found

Resistance and support

R1 7.9
R2 7.9
R3 7.9
Pivot

7.91

S1 7.9
S2 7.9
S3 7.9
EMA SMA
7.2
6.3
5.6
4.9
7.2
5.8
5.3
4.9
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
VARSHA CHUGH Bulk Purchase 2024-06-10 7.91 54838 BSE
GOPALSINGH JAYSINGH SOLANKI Bulk Sell 2024-06-10 7.91 73407 BSE
KOTHARI VINOD FOJMALJI Bulk Purchase 2020-09-03 2.73 30000 BSE
Name Category Shares
RAHUL ANANTRAI MEHTA PUBLIC 4.7%
MANJULA VINOD KOTHAR PUBLIC 3.34%
P B PRADEEP . PUBLIC 2.13%
ANUPRIYA SUREKA PUBLIC 2.06%
DHEERAJ ANANTH KUMAR PUBLIC 1.85%
ANANTH KUMAR TEJA SHREE PUBLIC 1.83%
B V CHANDAN YADAV PUBLIC 1.8%
GOPALSINGH JAYSINGH SOLANKI PUBLIC 1.67%
K SATISH PUBLIC 1.61%
G B BHAT PUBLIC 1.61%
SANJAYKUMAR RAMABHAI PATEL PUBLIC 1.46%
RAMESH RAI PUBLIC 1.37%
VINAY KUMAR V PUBLIC 1.32%
SHILPA SATISH PUBLIC 1.2%
DIVYA KANDA PUBLIC 1.16%
M Y THULASI MANI PUBLIC 1.15%
MANJUNATH B R PUBLIC 1.06%
HUF PUBLIC 1.21%
LANDMARK CAPITAL MARKETS LTD. PUBLIC 1.29%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Kabra Drugs Ltd Stocks COMPARISON

Financials( in Cr) Kabra Drugs Ltd Sun Pharmaceuticals Industries Ltd Divis Laboratories Ltd Cipla Ltd Zydus Lifesciences Ltd
Price 7.91 1,524.05 4,571.45 1,488.65 1,074.60
% Change 0 0.26 -0.67 0.65 0.68
Mcap Cr 3.47 365,670.65 121,357.83 120,188.69 108,129.91
Revenue TTM Cr 0.00 43,885.68 7,767.51 15,790.60 17,237.40
Net Profit TTM Cr -0.34 8,560.84 1,823.38 2,513.47 1,997.30
PE TTM 0.00 36.54 75.82 28.23 28.05
1 Year Return 46.48 47.58 27.43 48.60 85.79
ROCE 0.00 16.79 19.30 14.76 16.25
ROE 0.00 16.46 14.89 10.66 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: -0.73 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 20,359.03 25,446.17
LAST 3M 99,304.79 3,019.53
LAST 6M 185,012.32 -513.44
LAST 12M 297,786.95 84,654.14

Kabra Drugs Ltd Information

Stock PE (TTM)
0
Promoter Holding
0%
Book Value
2.4601
ROCE
0%
ROE
0%
Description
  • Kabra Drugs Ltd was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 1991. Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products. The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel. In India there are very few manufacturers who are manufacturing the said products. The company is the sole manufacturer of antimicrobial hand wash gel and other disinfectant products in India. The company is also a registered supplier to the Ministry of Defence. With manufacturing and regular supply in the domestic market for injectables, soft gelatin capsules and liquids (oral and external especially alcohol products) the company now looks at the global market. A number of new products have been developed for the same. Kabra Drugs are known to meet the diverse medical needs of patients in Emerging Markets in an innovative, socially responsible and commercially viable manner. Their products are manufactured at state of the art ultra modern plants with latest equipments backed by professional technocrats. These are WHO-GMP, cGMP & Schedule `M` approved facilities which also helps to get business approvals for Government, Semi- Government under takings , big institutions and other N.G.O`s. Besides, they are also actively involved in trading and marketing of biological API`s and Biochemicals. Due to scarcity of working capital funds, the Company is not able to perform any business activities. To make the Company operational, the Board is making its best effort to implement the cost reduction measures to the extent feasible. Several cost cutting measures have already been undertaken by the Company.

Registered Address

270 Shastri Market Indore, , Indore, Madhya Pradesh, 452007

Email : kabradrugs:gmail.com
Registrar

Ankit Consultancy Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524322
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : XT
ISIN : INE323K01017

FAQ’s on Kabra Drugs Ltd Shares

You can buy Kabra Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Kabra Drugs Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 01, 2024 04:01 PM the closing price of Kabra Drugs Ltd was Rs.7.91.

The latest PE ratio of Kabra Drugs Ltd as of Jul 01, 2024 04:01 PM is 0.00

The latest PB ratio of Kabra Drugs Ltd as of Jul 01, 2024 04:01 PM is 0.31

The 52-week high of Kabra Drugs Ltd share price is Rs. 7.91 while the 52-week low is Rs. 3.18

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 01, 2024 04:01 PM, the market cap of Kabra Drugs Ltd stood at Rs. 3.47 Cr.

Download App

Download Our App

Play Store App Store
market app